Improving electroconvulsive therapy settings and monitoring
Part of Brain & nervous system clinical trials.
This study helps doctors find the best settings for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. Researchers will use special monitoring equipment to measure brain activity during your ECT sessions to improve how the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be receiving electroconvulsive therapy at Pennsylvania Hospital
- You must be willing to participate in optical brain monitoring during your ECT sessions
- You cannot have other significant psychiatric conditions that would make the study unsafe for you
- You cannot have had poor results from ECT in the past
- You must be healthy enough physically to safely complete the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This study looks at “neural biomarkers,” or brain-measurement signals, to see who is most likely to benefit from electroconvulsive therapy (ECT). It focuses on people with certain active psychosis symptoms and specific mental health diagnoses who have tried antipsychotic medication without enough improvement.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study looks for ways to predict how well electroconvulsive therapy (ECT) will work for severe depression. It may help doctors choose the best treatment approach and timing for future patients.
This trial studies which electrical “pulse settings” work best during electroconvulsive therapy (ECT) for people with depression. It may help doctors personalize ECT so the treatment is safer and works as well as possible for you.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.